BG63973B1 - Хипнотични бета-карболинови производни, метод за тяхното получаване и използването им като лекарствени средства - Google Patents

Хипнотични бета-карболинови производни, метод за тяхното получаване и използването им като лекарствени средства Download PDF

Info

Publication number
BG63973B1
BG63973B1 BG104768A BG10476800A BG63973B1 BG 63973 B1 BG63973 B1 BG 63973B1 BG 104768 A BG104768 A BG 104768A BG 10476800 A BG10476800 A BG 10476800A BG 63973 B1 BG63973 B1 BG 63973B1
Authority
BG
Bulgaria
Prior art keywords
methoxy
quinolizin
derivatives
general formula
hexahydroindol
Prior art date
Application number
BG104768A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG104768A (en
Inventor
Jean-Bernard Fourtillan
Marianne Fourtillan
Jean-Claude Jacquesy
Marie-Paule Jouannetaud
Bruno Violeau
Omar Karam
Original Assignee
Macef
Laboratoires Besins Iscovesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/042,990 external-priority patent/US6048868A/en
Application filed by Macef, Laboratoires Besins Iscovesco filed Critical Macef
Publication of BG104768A publication Critical patent/BG104768A/xx
Publication of BG63973B1 publication Critical patent/BG63973B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG104768A 1998-03-17 2000-09-14 Хипнотични бета-карболинови производни, метод за тяхното получаване и използването им като лекарствени средства BG63973B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/042,990 US6048868A (en) 1994-09-14 1998-03-17 Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products
PCT/IB1999/000494 WO1999047521A1 (en) 1998-03-17 1999-03-17 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS

Publications (2)

Publication Number Publication Date
BG104768A BG104768A (en) 2001-05-31
BG63973B1 true BG63973B1 (bg) 2003-08-29

Family

ID=21924862

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104768A BG63973B1 (bg) 1998-03-17 2000-09-14 Хипнотични бета-карболинови производни, метод за тяхното получаване и използването им като лекарствени средства

Country Status (24)

Country Link
EP (1) EP1064284B1 (zh)
JP (1) JP4333036B2 (zh)
CN (1) CN1115342C (zh)
AR (1) AR018767A1 (zh)
AT (1) ATE215087T1 (zh)
AU (1) AU752364B2 (zh)
BG (1) BG63973B1 (zh)
BR (1) BR9908833A (zh)
CA (1) CA2324270A1 (zh)
DE (1) DE69901098T2 (zh)
DK (1) DK1064284T3 (zh)
ES (1) ES2174632T3 (zh)
HU (1) HUP0101234A3 (zh)
IL (1) IL138442A (zh)
IS (1) IS2199B (zh)
NO (1) NO317296B1 (zh)
NZ (1) NZ506913A (zh)
PL (1) PL193450B1 (zh)
PT (1) PT1064284E (zh)
RU (1) RU2210571C2 (zh)
SK (1) SK284387B6 (zh)
TR (1) TR200003596T2 (zh)
UA (1) UA71911C2 (zh)
WO (1) WO1999047521A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824829B1 (fr) * 2001-05-16 2005-06-03 Macef Nouveaux derives de dihydroimidazo [5,1-a]-beta-carboline, leur procede de preparation et leur application a titre de medicament
FR2904973A1 (fr) * 2006-08-18 2008-02-22 Fourtillan Snc Derives de 1-methylidene-pyrido[3,4-b]indole et leur utilisation en therapeutique.
FR2916200A1 (fr) * 2007-05-18 2008-11-21 Fourtillan Snc Nouveaux derives des 1,2,3,4,6,7,12,12a-octahydro pyrazino[1',2':1,6]pyrido[3,4-b]indoles, leur preparation et leur utilisation en therapeutique
MX2010007430A (es) 2008-01-11 2010-12-21 Albany Molecular Res Inc Piridoindoles (1-azinona)-sustituidos como antagonistas de la hormona de concentracion melanina humana.
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
EP2448585B1 (en) 2009-07-01 2014-01-01 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
FI130627B (en) * 2021-03-31 2023-12-18 Equinorm Ltd NEW HETEROCYCLIC COMPOUNDS AND THEIR USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283343A (en) * 1987-08-17 1994-02-01 Whitby Research, Inc. 2-aryl substituted N-acetyltryptamines and process of preparing such
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament

Also Published As

Publication number Publication date
CN1115342C (zh) 2003-07-23
SK284387B6 (sk) 2005-02-04
EP1064284B1 (en) 2002-03-27
WO1999047521A1 (en) 1999-09-23
HUP0101234A2 (hu) 2001-12-28
PL342929A1 (en) 2001-07-16
DE69901098T2 (de) 2002-11-21
NO20004638L (no) 2000-11-16
EP1064284A1 (en) 2001-01-03
DK1064284T3 (da) 2002-07-22
NO317296B1 (no) 2004-10-04
ATE215087T1 (de) 2002-04-15
BG104768A (en) 2001-05-31
IL138442A (en) 2006-12-10
IS2199B (is) 2007-02-15
AR018767A1 (es) 2001-12-12
BR9908833A (pt) 2000-11-21
SK13852000A3 (sk) 2001-09-11
ES2174632T3 (es) 2002-11-01
CA2324270A1 (en) 1999-09-23
PL193450B1 (pl) 2007-02-28
CN1299361A (zh) 2001-06-13
AU3270799A (en) 1999-10-11
IL138442A0 (en) 2001-10-31
PT1064284E (pt) 2002-09-30
JP2002506867A (ja) 2002-03-05
TR200003596T2 (tr) 2001-04-20
NZ506913A (en) 2003-07-25
HUP0101234A3 (en) 2002-12-28
AU752364B2 (en) 2002-09-19
IS5627A (is) 2000-09-12
UA71911C2 (en) 2005-01-17
JP4333036B2 (ja) 2009-09-16
DE69901098D1 (de) 2002-05-02
NO20004638D0 (no) 2000-09-15
RU2210571C2 (ru) 2003-08-20

Similar Documents

Publication Publication Date Title
JP4061658B2 (ja) 薬剤として有用なメラトニンおよびその類似物のアシル化誘導体
JP4051712B2 (ja) 新規メラトニン作用性のβ−カルボリン誘導体とナフタレン構造を含むその類似物、それらの製造方法および医薬品としての用途
KR900007780B1 (ko) 축합된 피롤리논 유도체의 제조방법
US5763471A (en) Melatoninergic agonist spiro indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products
US5801183A (en) Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
JP2010523725A (ja) 皮膚疾患処置用ホスホジエステラーゼ阻害剤としてのトリアゾロピリジン
JP2003528096A (ja) デカヒドロ−イソキノリン
EA002272B1 (ru) Производные замещенных индазолов, их применение в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продукции фактора некроза опухолей (фно)
BG63973B1 (bg) Хипнотични бета-карболинови производни, метод за тяхното получаване и използването им като лекарствени средства
JP7041141B2 (ja) 置換された二環式ヘテロアリール系ニコチン性アセチルコリン受容体アロステリック調節剤
JPH04226985A (ja) イミダゾナフチリジン誘導体
CA2317515A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
EP3560920A1 (en) Secondary alcohol quinolinyl modulators of ror gamma t
US6335346B1 (en) Pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
EA005071B1 (ru) ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ
JPS62181278A (ja) ５，６，７，８―テトラヒドロ―β―カルボリン誘導体及びその製法
JP2004537555A (ja) 化合物
JP4008059B2 (ja) 松果体ホルモン作用薬
MXPA00009139A (en) HYPNOTIC&bgr;-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
CZ20003279A3 (cs) Uspávači beta karbolinové deriváty, způsob jejich přípravy a použití v lékařství
KR20240089748A (ko) 방법
US4612311A (en) 1,2,4-benzothiadiazine oxide derivatives
JP2005526774A (ja) 環状エーテルアミン誘導体